The market for vascular surgery is not just substantial; it's thriving. With 236 million individuals worldwide affected by peripheral arterial disease (PAD), and 8.5 million of them in the United States, the demand for innovative solutions is evident. The Total Addressable Market (TAM) is projected to reach $10.4 billion in the US and $16 billion globally by 2026. EVI aims to capture a significant portion of this market, potentially translating into $1.6 billion in annual sales. Investing in EVI means being a part of an industry that's poised for exponential growth, offering you an opportunity to make a remarkable impact on patient well-being and the healthcare landscape.

EVI's vision is grounded in innovation, precision, and a patient-first approach. We've developed a suite of groundbreaking medical devices, each carefully designed to provide less invasive, more cost-effective, and longer-lasting solutions for vascular surgery. By investing in EVI, you're supporting our commitment to redefine the standards of care, improve patient outcomes, and change the way the world views vascular surgery.

Your investment in EVI is not just financial; it's a commitment to making a profound difference in the lives of patients worldwide. You'll be contributing to the advancement of medical science, empowering surgeons with innovative tools, and ultimately improving the well-being of individuals suffering from PAD. Join us in this extraordinary journey where your investment aligns with our vision to clear the way for better outcomes.